CSCO
61
-3
EL
37
-3
HBAN
56
2
F
40
-3
HIG
54
2
RRC
63
8
ROST
66
-2
APH
64
3
LEN
46
-3
LEG
36
5
CINF
31
2
IRM
41
3
CHD
34
-5
CLX
65
-4
BA
65
2
PPL
44
-3
AME
54
-5
GOOGL
72
5
PCG
56
-2
PHM
55
-3
CSCO
61
-3
EL
37
-3
HBAN
56
2
F
40
-3
HIG
54
2
RRC
63
8
ROST
66
-2
APH
64
3
LEN
46
-3
LEG
36
5
CINF
31
2
IRM
41
3
CHD
34
-5
CLX
65
-4
BA
65
2
PPL
44
-3
AME
54
-5
GOOGL
72
5
PCG
56
-2
PHM
55
-3
Financhill
Back

RBC Quant EAFE Div Ldrs(CAD Hedged) ETF Vs. Aligos Therapeutics Industry Stock Comparison

Buy
72

RIDH.TO
RBC Quant EAFE Div Ldrs(CAD Hedged) ETF

Last Price:
29.17
Seasonality Move:
0.98%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
33.60
Seasonality Move:
10.65%
Buy
72
RBC Quant EAFE Div Ldrs(CAD Hedged) ETF (RIDH.TO) is a Buy

Is RBC Quant EAFE Div Ldrs(CAD Hedged) ETF a Buy, Sell or Hold?

  • The current RBC Quant EAFE Div Ldrs(CAD Hedged) ETF [RIDH.TO] share price is $29.30. The Score for RIDH.TO is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • RIDH.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RIDH.TO Stock Price Chart

What is RBC Quant EAFE Div Ldrs(CAD Hedged) ETF's stock price today?

  • The RBC Quant EAFE Div Ldrs(CAD Hedged) ETF share price today is $29.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIDH.TO is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RIDH.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 64.52 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.4 - 29.14) Buy
Bollinger Bands (100): (28.41 - 29.35) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

RIDH.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.19 Buy
20-day SMA: 28.74 Buy
50-day SMA: 28.96 Buy
200-day SMA: 28.85 Buy
8-day EMA: 29.14 Buy
20-day EMA: 28.94 Buy
50-day EMA: 28.9 Buy
200-day EMA: 28.45 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

RBC Quant EAFE Div Ldrs(CAD Hedged) ETF Earnings Growth & RIDH.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

RBC Quant EAFE Div Ldrs(CAD Hedged) ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):